ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Oct 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
November 2025
Nuclear Technology
October 2025
Fusion Science and Technology
Latest News
A focus on clean energy transition
Michigan-based consulting firm Ducker Carlisle has released a report that outlines projected developments and opportunities as well as potential problems in the global shift to cleaner power. Global Energy Transition Outlook predicts that market growth will happen not only in large-scale utility upgrades but also in small- and mid-scale electrification projects.
V. Abella, R. Miró, B. Juste, G. Verdú
Nuclear Technology | Volume 175 | Number 1 | July 2011 | Pages 53-57
Technical Paper | Special Issue on the 16th Biennial Topical Meeting of the Radiation Protection and Shielding Division / Radiation Transport and Protection | doi.org/10.13182/NT11-A12269
Articles are hosted by Taylor and Francis Online.
This work is focused on coupling PLanUNC (PLUNC), a set of software tools for radiotherapy treatment planning (RTP), with MCNP5 Monte Carlo N-Particle transport code, utilizing the RANDO phantom as the patient model and the Elekta Precise linac as the irradiation source for comparison. Thus, the main goal of this paper is to compare the results obtained from the default calculations of the treatment plan software with those obtained via the implementation of MCNP5 calculations. Monte Carlo techniques have been proved to be a more accurate dose calculation aid than conventional treatment planning systems, having the only limitation of computer time. The implementation of MCNP5 calculations in a commercial RTP software aims to provide more accurate dose mapping of the patient in reasonable computer times. The results obtained in this paper represent a significant contribution in the development of RTP patient dose simulations.
